On one hand, TMAO can stimulate inflammation and endothelial dysfunction by activating the reactive oxygen species/thioredoxin-interacting protein (TXNIP)/NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome pathway.97 The gene discussed is TXNIP; the disease is endothelial dysfunction.